ELV - Educational Analysis * US Equities
Educational Analysis * US Equities

ELV

Earnings behavior, post-earnings drift, and the gap between consensus and the market's real expectation - the educational primer before you look at the institutional verdict.

Educational content only - not investment advice. Nothing on this page is a recommendation to buy or sell any security. Historical patterns do not predict future outcomes. Consult a licensed financial advisor before making any trading decision.
Published byGamma QC editorial
TickerELV
CategoryEducational primer
Last reviewedAugust 3, 2026
You're viewing an older edition of this page.Read the latest edition →

How ELV Has Actually Traded Around Earnings

Elevance Health (ELV) has beaten earnings expectations in 6 of its last 8 reported quarters, a 75% beat rate, with an average earnings surprise of 7.2%. That sounds like a clear bullish track record on the surface, but the post-earnings price action tells a more complicated story. Across those same eight quarters, the average 5-day price move in the trading days after the report has been +2.78%, classified as an "up" drift.

Yet that +2.78% average masks wide individual outcomes, and it does not mean a beat reliably produces a pop and hold. Looking at the last four reported quarters, ELV beat every time but the follow-through was inconsistent. On July 15, 2026, EPS came in at $7.45 versus the $6.21 estimate, a 20% surprise, and the stock still fell 4.48% the next day and 0.32% over the following five sessions. On October 21, 2025, EPS of $6.03 beat the $4.93 estimate by 22.3%, yet the stock dropped 1.3% the next day and 2.96% over the next five trading days. By contrast, the April 22, 2026 report delivered $12.58 versus $10.82, a 16.3% beat, and the stock rallied 5.51% the next day and 14.76% over the following five sessions. The takeaway is that the headline surprise is only one input; how the market has already positioned itself, and what management says about forward guidance, can drive the reaction more than the EPS beat itself.

Options-Flow Dynamics Heading into the October 21, 2026 Report

ELV's next scheduled earnings release is October 21, 2026, before the market open, with a consensus EPS estimate of $4.73. In the weeks leading into that date, options markets are pricing in an expected move that can be observed through near-the-money straddle pricing and changes in implied volatility. Traders often look at whether the options market is pricing a larger or smaller move than the stock's realized post-earnings history; with an average 5-day drift of +2.78%, any options-implied move materially above or below that range can signal positioning.

Current context also matters. ELV's price is $378.06, its RSI is 43.9, and the 50-day EMA sits at $387.00, meaning the stock is trading below a commonly watched intermediate-term average heading into the release. Options flow around earnings can reflect hedging by institutions already long the stock, directional speculation, or volatility sellers expecting a post-report implied-volatility collapse. None of those flows guarantee which way the stock will move, but unusually heavy call or put volume at specific strikes can highlight where the market's real expectation for price movement is clustered.

What a Disciplined Trader Watches for ELV

For a stock with this pattern, the first thing to watch is the gap relative to the consensus estimate on the morning of October 21, 2026. A beat is not a signal by itself; what matters is how the result compares to the market's real expectation and whether management commentary changes the forward narrative. The second thing to watch is whether the first day's move extends or reverses over the following five sessions. Historical examples from July 2026 and October 2025 show that even large positive surprises can be sold immediately, while April 2026 shows a beat can fuel a multi-day trend.

Risk management also comes down to specific levels. With the stock at $378.06 and below the 50-day EMA at $387.00, any post-earnings move needs to be evaluated against that technical backdrop, not in isolation. A disciplined approach compares the size of the EPS surprise, the direction of the first-day gap, the five-session drift, and whether volume confirms the move. For a deeper dive into how institutional analysts are interpreting these same signals, readers should review the full institutional verdict on ELV.

Frequently Asked Questions

What is ELV's historical earnings beat rate and average surprise?

Over the last eight reported quarters, ELV has beaten earnings estimates 6 times, for a 75% beat rate, with an average earnings surprise of 7.2%.

Has ELV always gone up after beating earnings estimates?

No. On July 15, 2026, ELV beat by 20% but fell 4.48% the next day and 0.32% over the following five sessions. On October 21, 2025, it beat by 22.3% but dropped 1.3% the next day and 2.96% over five sessions. However, on April 22, 2026, a 16.3% beat produced a 5.51% next-day gain and a 14.76% five-session rally.

When is ELV's next earnings report and what is the consensus estimate?

ELV is scheduled to report next on October 21, 2026, before the market open, with a consensus EPS estimate of $4.73.

Real Data - Gamma QC Earnings IntelligenceAs of Aug 3, 2026
Elevance Health Inc. · Healthcare / Medical - Healthcare Plans
$82.0BMarket cap
16.8P/E
2.5%Net margin
11.2%ROE
75%Beat rate, last 8Q
7.2%Avg EPS surprise
2.78%Avg 5-day move after earnings
2026-10-21Next earnings
ReportedActualEstimateSurprise1D Move5D Move
2026-07-15$7.45$6.21+20%-4.48%-0.32%
2026-04-22$12.58$10.82+16.3%+5.51%+14.76%
2026-01-28$3.33$3.1+7.4%+1.5%-0.37%
2025-10-21$6.03$4.93+22.3%-1.3%-2.96%
2025-07-17$8.84$8.91-0.8%--
2025-04-22$11.97$11.41+4.9%--

Previous ELV editions

Beyond the primer

Get the institutional verdict on ELV

Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.

Read the ELV verdict at Gamma QC
$49 Pro / $249 RIA * gammaqc.com

Verify authenticity

Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.